Legend Biotech Corp (LEGN) — Institutional Holders, Q2 2026 (page 3)

219 institutional investment managers reported a LEGN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.0B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 219. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

LEGN 13F holders ranked 201–219 of 219

Institutional investors reporting a position in Legend Biotech Corp on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
True Wealth Design#201 · 109 sh$3.1K+473.7%
Pinnacle Wealth Planning Services#202 · 95 sh$2.7K-76.8%
Ronald Blue#203 · 83 sh$2.4KNew
Larson Financial Group#204 · 64 sh$1.8KNew
ZRC WEALTH MANAGEMENT#205 · 48 sh$1.4KNew
HRT FINANCIAL#206 · 48,000 sh$1.4KNew
SHP Wealth Management#207 · 48 sh$1.4K0.0%
Bare Financial Services#208 · 39 sh$1.1K0.0%
ACTION POINT FINANCIAL PLANNING#209 · 36 sh$982.00New
Versant Capital Management#210 · 20 sh$578.00New
Physician Wealth Advisors#211 · 17 sh$491.00-69.1%
RAFFA WEALTH MANAGEMENT#212 · 16 sh$462.000.0%
Bell Investment Advisors#213 · 14 sh$405.00New
NORTHWESTERN MUTUAL WEALTH MANAGEMENT#214 · 13 sh$375.00+44.4%
Trust Co#215 · 11 sh$318.000.0%
SBI Securities , Ltd.#216 · 10 sh$289.00-92.6%
JONES FINANCIAL COMPANIES LLLP#217 · 9 sh$258.00-50.0%
Transamerica Financial Advisors#218 · 1 sh$28.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#219 · 11,684 sh—-1.3%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.